R John Fletcher is Director of AXCELIS TECHNOLOGIES INC. Currently has a direct ownership of 1,354 shares of ACLS, which is worth approximately $192,525. The most recent transaction as insider was on Feb 17, 2021, when has been sold 6,881 shares (Common Stock) at a price of $39.0 per share, resulting in proceeds of $268,359. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.35K
0% 3M change
0% 12M change
Total Value Held $192,525

R JOHN FLETCHER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 17 2021
SELL
Open market or private sale
$268,359 $39.0 p/Share
6,881 Reduced 83.56%
1,354 Common Stock

Also insider at

CLPT
ClearPoint Neuro, Inc. Healthcare
KRMD
KORU Medical Systems, Inc. Healthcare
VYNT
Vyant Bio, Inc. Healthcare
OPTN
OptiNose, Inc. Healthcare
RJF

R John Fletcher

Director
Cherry Hill,, NJ

Track Institutional and Insider Activities on ACLS

Follow AXCELIS TECHNOLOGIES INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACLS shares.

Notify only if

Insider Trading

Get notified when an Axcelis Technologies Inc insider buys or sells ACLS shares.

Notify only if

News

Receive news related to AXCELIS TECHNOLOGIES INC

Track Activities on ACLS